Matthew Scholz
CEO of Oisin Biotechnologies & OncoSenX
Contact
- Social accounts: linkedin
Companies
Company
Roles
Oisin Biotechnologies
Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.
CEO
OncoSenX
OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.
CEO